Macroaxis Stories

Reasons Agilent Technologies (USA Stocks:A) can excite investors

August 2, 2023  By Nico Santiago
Macroaxis Story
Agilent Technologies, a prominent player in the Healthcare sector and specifically in the Life Sciences Tools & Services category, has seen its stock (USA Stocks:A) surge over 4% despite a slight market downturn. This international/domestic company, listed on the NYSE, boasts a robust enterprise value of $37.7B and a market capitalization matching its enterprise value. Agilent's financial health is evident in its impressive operating margin of 25.11% and a profit margin of 19.19%. The company's EBITDA stands at a substantial $2.1B, further underlining its strong financial position. Agilent's gross profit is reported at $3.7B, and its net income from continuing operations is $1.3B, applicable to common shares. The company's revenue per share is $23.704, with total revenue reported at $7B. Agilent's income before tax is $1.5B, with a change to net income of $219M. Despite these impressive figures, the company is not without potential risks. The possible downside price is estimated at $125, according to analysts. Agilent Technologies has a dividend per share of $0.87, a testament to its commitment to rewarding its shareholders. The company's enterprise value revenue is 6.9195, and it has a CIK of 1.1M. According to 12 estimates from analysts, the highest estimated target price for Agilent's stock is $170. Despite the slight market downturn, Agilent Technologies continues to demonstrate its resilience and potential for growth. Agilent Technologies' Working Capital is projected to decrease significantly, based on the last few years of reporting. The Working Capital for the past year was at 1.73 billion. The current year's Receivables Turnover is expected to increase to 7.01, while the Net Income Per Employee is forecasted to decline to approximately $52.2K. Many of us are enthusiastic about the life sciences tools and services sector, making it worthwhile to examine Agilent Technologies. Despite the challenges, we remain optimistic about a swift recovery. In this article, I will also discuss various factors influencing Agilent Technologies' products and services, and explain how these may impact the company's investors.
Published over a year ago
View all stories for Agilent Technologies | View All Stories

Reviewed by Rifka Kats

Agilent Technologies, a prominent player in the Healthcare Equipment & Supplies industry, has seen its stock price surge over 4% despite a slight market downturn. The company, traded on the NYSE under the ticker A, has an impressive enterprise value of 37.7B, demonstrating its substantial market presence. Agilent's operating income stands at 1.6B, indicating a strong financial performance. The company's gross profit is an impressive 3.7B, further highlighting its profitability. Despite a total risk alpha of -0.31, indicating some level of risk, the company's earnings per share of 4.53 suggest that it could be a worthwhile investment. However, potential investors should also consider the company's income tax expense of 250M and a mean deviation of 1.1, which indicates a certain level of volatility in the stock's return.

A deeper look at Agilent

The average rating for the company is "Buy," as suggested by 12 analysts. Macroaxis provides advice on Agilent Technologies, serving to complement and cross-verify the current analyst consensus on Agilent Technologies. Our investment recommendation engine assesses the company's growth potential exclusively from the perspective of an investor's current risk tolerance and investment horizon.
The performance of Agilent Technologies in the marketplace will significantly impact your decision to invest in its stock. Revenue growth, profitability, competitive positioning, management quality, and industry trends can influence Agilent Technologies' stock prices. When investing in Agilent Technologies, there are several factors to consider and potential outcomes to expect. As a company performs well, its stock price may increase, allowing investors to benefit from price appreciation. However, Agilent Stock can experience significant price fluctuations due to market conditions, economic factors, industry trends, or company-specific news. This is why investing in stocks such as Agilent Technologies carries risks, including the potential for capital loss. Stock prices can decline, and investors may incur losses if they sell shares at a lower price than their initial investment.

How important is Agilent Technologies's Liquidity

Agilent Technologies financial leverage refers to using borrowed capital as a funding source to finance Agilent Technologies ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Agilent Technologies financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to Agilent Technologies' owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of Agilent Technologies' financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the breakdown between Agilent Technologies's total debt and its cash.

What do experts say?

Stock analysis is a method for investors and traders to make buying and selling decisions. By studying and evaluating past and current data, investors and traders attempt to gain an edge in the markets by making informed decisions. It is good to see analyst projects for Agilent Technologies, but it might be worth checking our own buy vs. sell analysis

Agilent Technologies Gross Profit

Agilent Technologies Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing Agilent Technologies previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show Agilent Technologies Gross Profit growth over the last 10 years. Please check Agilent Technologies' gross profit and other fundamental indicators for more details.

Breaking down Agilent Technologies Indicators

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Agilent Technologies has an asset utilization ratio of 65.12 percent. This suggests that the company is making $0.65 for each dollar of assets. An increasing asset utilization means that Agilent Technologies is more efficient with each dollar of assets it utilizes for everyday operations.
 2020 2021 2022 2023 (projected)
Receivables1.17 B1.41 B1.26 B1.05 B
Inventories830 M1.04 B1.19 B1.09 B
ReceivablesInventories
Agilent Technologies (A.US), a key player in the Healthcare Equipment & Supplies industry, has seen its stock surge over 4% despite a slight market downturn. This performance is noteworthy considering the company's operating margin of 0.25% and a five-year return of 0.73%. The company, which employs 18.4K full-time employees, has a net asset value of $10.52B and total debt of $2.77B.
Agilent's current valuation stands at $37.68B, with an enterprise value of $37.7B. The company's price to book ratio is 8.63X, and it has a PE ratio of 28.1921. Despite a net interest income loss of $75M, the company has managed to maintain a healthy operating income of $1.6B and a net income from continuing operations of $1.3B. The company's EPS estimate for the current year is 5.5, with an EPS estimate of 5.98 for the next year. Agilent's revenue per share is 23.704, and it has a profit margin of 0.19%. Despite the market's volatility, Agilent Technologies continues to show strong performance, making it a potential consideration for investors in the healthcare sector. .

Our perspective of the current Agilent Technologies rise

Despite the recent surge in Agilent Technologies' stock, it's essential to consider the negative Jensen's Alpha of -0.15. This figure suggests that the stock is underperforming the market, given the associated risk. While the current upward trend may appear enticing, the negative alpha implies that investors may not be receiving adequate compensation for the risk they are undertaking. Therefore, it's recommended to proceed with caution and closely monitor the stock before making any substantial investment decisions. Agilent Technologies displays very low volatility, with a skewness of -0.67 and a kurtosis of 3.07. However, we encourage investors to further examine Agilent Technologies' technical indicators to ensure all market information is available and reliable. Understanding various market volatility trends often assists investors in timing the market. Proper utilization of volatility indicators allows traders to measure Agilent Technologies' stock risk against market volatility during both bullish and bearish trends. The heightened level of volatility that accompanies bear markets can directly affect Agilent Technologies' stock price, adding stress to investors as they watch the value of their shares decline.
This situation typically compels investors to rebalance their portfolios by purchasing different stocks as prices drop. In light of the recent performance of Agilent Technologies (USA Stocks:A), the investment outlook appears positive. Despite a modest market slip, the stock has built up over 4 percent, outperforming the market. The company's valuation real value stands at 134.58, significantly higher than the possible downside price of 125. Moreover, the analyst target price estimated value is 143.416, suggesting potential for further growth. With 8 strong buy recommendations and an overall consensus of 'Buy', Agilent presents a compelling investment case. However, investors should also consider the possible upside price of 128.2 and the lowest estimated target price of 126. Given these factors, Agilent Technologies seems to be a promising investment opportunity. .

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Editorial Staff

Nico Santiago is a PR Contributor to Macroaxis Editorial Board. Nico is a relatively new author here at Macroaxis and he likes to work on advertising and sponsored content and marketing for the company. Nico spends most of his time surfing when the weather is nice and he spends the rest of the year writing for various blogs and companies, as he works on his upcoming books, The Rise of the Financial Machines and Time Series Modelling with AI. View Profile
This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Nico Santiago do not own shares of Agilent Technologies. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com